Global Medical REIT Statistics
Share Statistics
Global Medical REIT has 20.71M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding | 20.71M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | n/a |
FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 3.57K, so undefined% of the outstanding
shares have been sold short.
Short Interest | 3.57K |
Short % of Shares Out | n/a |
Short % of Float | 0.02% |
Short Ratio (days to cover) | 0.43 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.16 |
Forward PS | n/a |
PB Ratio | 1.25 |
P/FCF Ratio | n/a |
PEG Ratio | undefined |
Financial Ratio History Enterprise Valuation
Global Medical REIT has an Enterprise Value (EV) of 1.34B.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25,
with a Debt / Equity ratio of undefined.
Current Ratio | 2.25 |
Quick Ratio | 2.25 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | undefined |
Financial Efficiency
Return on Equity is 0.04% and Return on Invested Capital is 3.1%.
Return on Equity | 0.04% |
Return on Assets | 0.02% |
Return on Invested Capital | 3.1% |
Revenue Per Employee | $5,420,538.46 |
Profits Per Employee | $792,769.23 |
Employee Count | 26 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -1.18% in the
last 52 weeks. The beta is 1.28, so Global Medical REIT's
price volatility has been higher than the market average.
Beta | 1.28 |
52-Week Price Change | -1.18% |
50-Day Moving Average | 25.23 |
200-Day Moving Average | 25.08 |
Relative Strength Index (RSI) | 49.42 |
Average Volume (20 Days) | 5,324 |
Income Statement
In the last 12 months, Global Medical REIT had revenue of 140.93M
and earned 20.61M
in profits. Earnings per share was 0.23.
Revenue | 140.93M |
Gross Profit | 54.72M |
Operating Income | 37.94M |
Net Income | 20.61M |
EBITDA | 111.64M |
EBIT | 37.94M |
Earnings Per Share (EPS) | 0.23 |
Full Income Statement Balance Sheet
The company has 1.28M in cash and 618.91M in
debt, giving a net cash position of -617.63M.
Cash & Cash Equivalents | 1.28M |
Total Debt | 618.91M |
Net Cash | -617.63M |
Retained Earnings | -238.98M |
Total Assets | 1.24B |
Working Capital | -635.25M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 68.44M
and capital expenditures -10.05M, giving a free cash flow of 58.39M.
Operating Cash Flow | 68.44M |
Capital Expenditures | -10.05M |
Free Cash Flow | 58.39M |
FCF Per Share | 0.89 |
Full Cash Flow Statement Margins
Gross margin is 38.82%, with operating and profit margins of 26.92% and 14.63%.
Gross Margin | 38.82% |
Operating Margin | 26.92% |
Pretax Margin | 15.42% |
Profit Margin | 14.63% |
EBITDA Margin | 79.21% |
EBIT Margin | 26.92% |
FCF Margin | 41.43% |